Cabazitaxel versus abiraterone or enzalutamide in poor prognosis metastatic castration-resistant prostate cancer: a multicentre, randomised, open-label, phase II trial
Annala, M., Fu, S., Bacon, J.V.W., Sipola, J., Iqbal, N., Ferrario, C., Ong, M., Wadhwa, D., Hotte, S.J., Lo, G., Tran, B., Wood, L.A., Gingerich, J.R., North, S.A., Pezaro, C.J., Ruether, J.D., Sridhar, S.S., Kallio, H.M.L., Khalaf, D.J., Wong, A., Beja, K., Schönlau, E., Taavitsainen, S., Nykter, M., Vandekerkhove, G., Azad, A.A., Wyatt, A.W., Chi, K.N.
Published in Annals of oncology (01.07.2021)
Published in Annals of oncology (01.07.2021)
Get full text
Journal Article
4MO Multi-focal genomic dissection of synchronous primary and metastatic tissue from de novo metastatic prostate cancer
Murtha, A.J., Warner, E., van der Eecken, K., Kwan, E., Herberts, C., Sipola, J., Ng, S., Chen, E., Fonseca, N., Schönlau, E., Bernales, C., Donnellan, G., Verbeke, S., Lumen, N., van Dorpe, J., De Laere, B., Annala, M., Vandekerkhove, G., Ost, P., Wyatt, A.W.
Published in Annals of oncology (01.10.2022)
Published in Annals of oncology (01.10.2022)
Get full text
Journal Article